؉ T cells seem to specifically express the CD122 receptor. Altogether, these observations demonstrate an increase in peripheral blood CD8 ؉ Tregs associated with aging.
INTRODUCTION
Normal aging is associated with the development of a series of events, collectively called immune senescence, and that leads to a reduced efficiency of the immune system responses. In fact, a reduced response to recall antigens, as well as an increased sensibility to infections and malignancy can be observed [1, 2] . In addition, an impaired self-tolerance can be evident, as can be deduced by the increased incidence of autoimmune diseases observed with aging. However, the mechanisms underlying these clinical effects remain poorly understood. Thymic involution in adults is associated with a marked reduction in thymic T cell output, as measured by decreased TCR excision circle ϩ T cells in subjects aged over 65 years and a reduction in the number of naïve CD45RA ϩ T cells [3, 4] . It is likely, therefore, that maintenance of the peripheral T cell pool in the elderly will depend on an increase in proliferation of existing T cells through peripheral expansion of T cells with affinity for foreign and self-antigen [5] . This phenomenon may at least partly explain the contraction of the TCR repertoire and the emergence of clonal T cell populations as seen in the memory compartment in elderly subjects [6, 7] . Impaired central tolerance and a reduction in the diversity of the T cell repertoire may be key factors in immune dysregulation in the elderly, and peripheral mechanisms for immune regulation may become increasingly important.
In the early 1970s, R. K. Gershon [8] suggested that T lymphocytes could act as regulatory cells, suppressing immune responses. However, these cells and the molecular mechanisms responsible for suppression were difficult to be characterized. Recently, advances in the identification of CD4 ϩ T cell subpopulations, together with the use of genetically modified mice, have led to a renaissance of this field, and regulatory T cells (Tregs) are now thought to be an additional mechanism by which peripheral self-tolerance is maintained, alongside T cell deletion and T cell anergy [9 -11] . The concept of Tregs is attractive, as it could explain how tolerance can be adoptively transferred by T cells, how pathological responses to self and harmless foreign antigens are prevented, and how bystander tissue insult is avoided during normal immune responses.
The existence of thymus-derived Tregs was suggested initially by the onset of autoimmune diseases in mice after thymectomy on Day 3 of life [12, 13] . These disorders were found to be a result of a loss of peripheral CD4 ϩ T cells that constitutively express IL-2R ϩ (CD25), which appears late in the periphery after birth [14] . Physiologically generated CD4 ϩ CD25 ϩ T cells inhibit a wide range of autoimmune and inflammatory disorders such as gastritis, oophoritis, orchitis, thyroiditis, colitis, and spontaneous autoimmune diabetes [15] [16] [17] [18] .
Despite numerous studies, the mechanisms by which CD4 ϩ CD25 ϩ T cells exert their regulatory function are unclear. Some studies have shown that regulation in vivo depends on the production of suppressive cytokines such as IL-10 and TGF-␤ and cell-surface molecules such as CD152 [19 -21] 
CD25
ϩ T cells support a cell contact-dependent, cytokine-independent mechanism of suppression [24] . In addition, there is evidence of an increasing of CD4 ϩ CD25 ϩ T cell subset in the peripheral blood with aging [25] [26] [27] [28] . CD8 ϩ T cells have been reported to be essential in vivo to prevent experimental autoimmune encephalomyelitis and to participate in oral tolerance [29 -31] . Nevertheless, the existence of a CD8
ϩ Treg subset has received less attention, despite earlier studies that identified CD8 populations with a suppressive effect. Otherwise, it has been shown that regulatory/suppressor CD8 ϩ CD28 -T cells can be generated/expanded in vitro by multiple rounds of stimulation with allogenic, xenogenic, or antigen-pulsed, syngenic APCs [32, 33] . In addition, it has been suggested that CD8
ϩ Tregs can act by regulating acute or established inflammation [34] and that they are present in the tumor-infiltrating lymphocyte population of cancer patients [35] .
Although several aspects of the biology, mechanism of action, and role of these cells remain to be elucidated, there is evidence that a Treg subset can be involved in cancer patients [34 -40] .
In this paper, we have analyzed CD8 
CD28
-Tregs from young and elderly subjects suppress proliferation and cytokine production in response to polyclonal T cell stimulation.
MATERIALS AND METHODS

Subjects
Forty healthy volunteers between the ages of 20 and 81 years were recruited into the study after informed consent. The donors were defined as "healthy" after answering a questionnaire excluding evident pathologies (i.e., autoimmune diseases, infectious diseases, acute inflammation, and cancer). The research was approved by the Ethical Committee of the University of Genova and San Martino Hospital (Italy) and was in accordance with the principles of the Helsinki II Declaration.
Flow cytometry
PBMC were isolated from peripheral blood samples by density centrifugation over Ficoll-Hypaque gradient. Antibodies used for flow cytometry were PE-, PE-CY5.5-, allophycocyanin-CY5-, or FITC-conjugated anti-CD3 (IgG1, clone UCHT1), anti-CD4 (IgG1, RPA-T4), anti-CD8 (IgG1 RPA.Tg), anti-CD25 (IgG1, BC96), anti-CD28 (IgG1, CD28.2), and anti-CD127 (IgG1, eBioRDR5; eBiosciences, San Diego, CA, USA); anti-CD62 ligand (CD62L; IgG1, LT-TD180), anti-CD45RO (IgG1, UCHL1), anti-CD38 (IgG1, HIT1), and anti-HLA-DR (IgG1, 1E5; ImmunoTools, Friesoythe, Germany); and anti-CD122 (IgG1, MIK-␤3; BD Biosciences, Hamburg, Germany). Appropriate fluorochrome-labeled, isotype-matched mAb were used as controls. For intracellular staining, immunomagnetic-sorted cells were fixed in 2% paraformaldehyde and permeabilized with 0.1% saponin before staining with anti-CD152 (IgG2a, 14D3), anti-forkhead box P3 (FoxP3; IgG2a, PCH101; eBiosciences), or isotype-matched control antibody. Flow cytometry was performed on a FACSCalibur (BD Biosciences). Unconjugated anti-CD28 mAb was a gift by D. Olive (Université de la Méditerranée, Cancer and Immunology Institute of Marseille, Marseille, France). 
Isolation of Tregs
Proliferation assays
RPMI-1640 medium supplemented with L-glutamine (2 mM), penicillin (100 IU/ml)/streptomycin (100 g/ml), and 10% human AB serum (all from Invitrogen, Milan, Italy) was used in all assays. Direct suppression "add-back" experiments were performed as described previously [41] . Briefly, 1 ϫ 10
-cells were incubated in the presence of PHA (Sigma Chemical Co., St. Louis, MO, USA) at 2 g/ml and 1 ϫ 10 4 -irradiated (30 Gy), autologous PBMC that had been depleted of T cells (CD3 microbeads, Miltenyi Biotec). Incubations were performed with
, at a ratio of 1:1. Similarly, incubations were performed with CD4 ϩ CD25 ϩ fractions, alone or in coculture 
Cytokine assays
-T cells were cocultured as above, and supernatants were evaluated after 72 h for IFN-␥, IL-4, IL-10, and TGF-␤ (Bender, Milan, Italy) production by ELISA.
Statistics
Statistical analysis was performed using GraphPad Prism software 4.0 (GraphPad Software Inc., San Diego, CA, USA). The nonparametric Spearman's rank correlation coefficient with two-tailed P value was used to assess the significance of correlation between frequency of CD8 ϩ CD28 -T cells or CD4 ϩ CD25 ϩ T cells and subject age. ANOVA analyses were performed to evaluate differences among the Treg frequency and the different age groups. Mann-Whitney analyses were performed to assess differences in young and elderly donor cell marker expression.
RESULTS
CD8
ϩ Tregs have a typical cell-surface phenotype PBMC from healthy donors were separated by immuno-beads cell sorting in two different populations expressing CD3 ϩ
ϩ CD28 ϩ (defined as cytotoxic) and CD3 ϩ CD8 ϩ CD28 Ϫ (defined as regulatory). In an attempt to identify markers characteristic for CD8 ϩ cytotoxic and CD8 ϩ Treg lymphocytes, we first compared their immunophenotype using a panel of mAb as shown in Figure 1 . This figure represents a staining of CD8 ϩ Tregs from a single donor. These patterns of expression were characteristic of this subpopulation of T cells, independently of the age donor.
Cytotoxic and Tregs express comparable levels of HLA-DR and CD8. On the contrary, CD28 expression was restricted to the cytotoxic T cell population. The lymphonode homing receptor CD62L was expressed slightly more in the cytotoxic T cell population, whereas Treg expressed a higher level of CD45RO and a lower level of CD44 than cytotoxic T cells (expressing an effector/memory immunophenotype). In addition, CD8
ϩ Tregs showed a higher expression of CD38. As expected, membrane expression of CD25 and cytoplasm expression of CD152 and FoxP3 molecules associated with CD4 ϩ CD25 ϩ Tregs were slightly higher in CD8 ϩ Tregs than in cytotoxic cells. Of interest, all cells expressing CD3 ϩ
ϩ CD28 Ϫ CD152 ϩ were positive for FoxP3 and negative or roughly negative for CD127 (data not shown). In fact, it has been shown that down-regulation of CD127 (the IL-7R) distinguishes Tregs from activated T cells, facilitating Treg purification and their functional characterization in human diseases [42] [43] [44] .
The final part of our phenotypic analysis focused on the expression of CD122 (the receptor for IL-2/IL-15R␤). CD122 binds two of the major maintenance and/or survival cytokines. We found that CD122 (IL-2/IL-15R␤) was preferentially expressed on the CD8 ϩ CD28 -Treg population (Fig. 1 ).
Tregs increase in peripheral blood with increasing age
Forty healthy volunteer donors were recruited into the study with an age range of 20 -81 years: 20 -30 years (nϭ7), 31-40 years (nϭ7), 41-50 years (nϭ7), 51-60 years (nϭ7), 61-70 years (nϭ6), and over 70 years (nϭ6). The frequency of CD8 ϩ CD28 -T cells and of CD4 ϩ CD25 ϩ (combined CD25 int -and CD25 high -expressing cells) within PBMC was performed by flow cytometry. Appropriate isotype controls were performed with each sample (Fig. 1) , and samples were run repeatedly with each batch to ensure consistency in the protocol. The percentage of CD8 ϩ CD28 -expressing T cells showed a steady rise in association with increasing subject age (rϭ0.9244, PϽ0.0001), and this effect was observed without a plateau ( Fig. 2A) . Similarly, the percentage of lymphocytes expressing CD4 ϩ CD25 ϩ increased significantly with age (rϭ0.9591; PϽ0.0001; Fig.  2B ). No correlation was observed between subject age and depleted APCs for 72 h. As shown in Figure 3A , equivalent suppression of CD4 ϩ
CD25
-T cell proliferation in response to PHA stimulation was observed in young and elderly subjects when CD8 ϩ CD28 -Tregs were added. Furthermore, there was no significant difference in the degree of suppression mediated for each reducing titration of CD8 
CD28
-T cell-mediated suppression in young and elderly individuals (Fig. 3A) . Similarly, there were no significant differences in the degree of CD4 ϩ
CD25
-T cell suppression mediated for each reducing titration of CD4 ϩ CD25 ϩ Tregs (Fig. 3B) .
Finally, production of IFN-␥ by CD4 ϩ CD25 -T cells in the above PHA stimulation was also inhibited by the addition in coculture of CD8 ϩ
CD28
-Tregs, and this effect was observed in young and elderly donors, respectively (Fig. 3C ).
Tregs in young and elderly subjects modulate cytokine production in vitro
The amount of IL-4, IL-10, and TGF-␤ released in the culture supernatant was tested in the same subjects investigated in proliferation experiments. The levels of cytokines released in the culture supernatant are shown in Table 1 . Before Treg addition in elderly donors, the level of IL-4, IL-10, and TGF-␤ secreted by CD4 ϩ CD25 -was slightly higher than in young donors.
In young and elderly donors, the direct addition of CD8 ϩ CD28 ϩ Tregs to CD4 ϩ CD25 -T cells resulted in an increase of IL-4, IL-10, and TGF-␤ in the supernatant. Although the changes in IL-4 were similar in young and elderly, the increase in IL-10 and TGF-␤ levels was significantly higher in the elderly (15.6-and 12.4-fold, respectively) than in the young (10.1-and 7.8-fold, respectively).
DISCUSSION
The interest in regulation of antigen-specific immune responses has led to the identification of T cell subsets that have suppressive properties. Many experimental models have been used to define Treg/suppressor T cells, which have been identified as CD4 ϩ , CD8 ϩ , or CD4/CD8 double-negative and shown to use myriad mechanisms from anti-idiotypic recognition and cytotoxicity to immune deviation, cytokine secretion, and "prohibition" of APCs. The best-characterized populations of Tregs are naturally occurring CD4 ϩ
CD25
ϩ Tregs from which a growing list of phenotypic markers, presumed to allow the unequivocal identification of Tregs, has been derived [40] . Moreover, evidence indicates that CD8 ϩ cells can also be divided into effector and regulatory subsets. CD8 ϩ effector cells have cytotoxic activity and can produce IFN-␥ or IL-4. CD8
ϩ Tregs, by contrast, lack cytotoxic activity and produce IL-10 or TGF-␤. In addition, they are hyporesponsive to secondary stimulation [45] .
The mechanism of action of CD8 ϩ Tregs bears many similarities to that of CD4 ϩ CD25 ϩ Tregs, including inhibition of IL-2 production in target cells, dependence on cell contact, and abrogation of suppression with PMA/ionomycin. Differently from CD4 ϩ CD25 ϩ -mediated suppression, reversed by exogenous IL-2, CD8
ϩ Treg-mediated inhibition is reversed by ligation of CD28 or TCR-mediated stimuli, but not IL-2. The lack of response to IL-2 is presumably a result of the observed blockade of CD25 up-regulation, which provides a high-affinity IL-2R. Studies of CD4 ϩ
ϩ cells and human CD8 ϩ Tregs suggest that suppression is mediated through APCs via downregulation of costimulatory molecules or up-regulation of inhibitory receptors. CD4 ϩ CD25 ϩ Tregs also suppress via direct T-T contact [46] .
Human CD4 ϩ CD25 ϩ T cells are known to be functionally heterogeneous and include cells with suppressive function and recently activated effector CD4 ϩ T cells [16] . However, characterization of CD4 ϩ CD25 ϩ T cells in elderly and young donors demonstrated no differences in terms of membrane activation markers or expression of CD152 [25] . The only phenotypic difference was the increased expression of CD45RO in CD4 ϩ CD25 high T cells in the elderly cohort, a phenomenon well described previously for CD4 ϩ T cells [17] . These observations suggest that the increase in CD4 ϩ CD25 ϩ T cells in the elderly is not a result of expansion of activated effector T cells and furthermore, that CD4 ϩ
ϩ T cells in this age group have a phenotype consistent with that reported previously for Tregs [25] . Together, these observations indicate
FoxP3
ϩ cells were accumulated in spleens and lymph nodes from old mice when compared with young animals [27] . In addition, it has been shown that the levels, phenotypes, and function of CD4 ϩ CD25 ϩ Tregs were altered significantly with aging in mice [28] .
The reasons for expansion of CD8 ϩ CD25 ϩ as well as CD4 ϩ CD25 ϩ Tregs with age are unclear. Against a background of progressive thymic atrophy and reduced, naïve T cell output, it is unlikely that the expansion of CD8 ϩ CD25 ϩ T cell numbers in the elderly is thymically derived, and therefore, the peripheral expansion of existing Tregs may be a predominant factor. In vitro, conventional CD4
ϩ CD25 -T cells may undergo induction to a Treg phenotype in the setting of impaired costimulation and under the influence of immunosuppressive cytokines such as 19] .
Recently, three different CD8 ϩ T suppressor cell subpopulations have been identified and functionally characterized in humans. One of these subsets is represented by CD8 ϩ CD28 Ϫ T cells, which inhibit alloantigen, xeno-antigen, and nominal, antigen-specific CD4 ϩ T cell responses. CD8 ϩ CD28 Ϫ T cells were generated in vitro by multiple rounds of stimulation of PBMC with allogeneic, xenogeneic, or antigen-pulsed, syngeneic APCs [34] . Another type of CD8 ϩ T cells was generated in vitro from purified, circulating CD8 ϩ lymphocytes incubated for 1 week with monocytes, IL-2, and GM-CSF. These cells inhibited the proliferative response of T cells stimulated with specific antigens, anti-CD3 mAb, or mitogens. Furthermore, they also seem to suppress the lysis mediated by cytotoxic cells [34] . A third subpopulation of CD8 ϩ suppressor lymphocytes has been identified recently [47] . These cells were generated by stimulating purified, naive CD8 ϩ T lymphocytes with plasmacytoid dendritic cells (DC). Their generation depends on antigen presentation and secretion of IL-10 by DC. The mechanism of action of this subset of CD8 ϩ suppressor cells is not yet understood completely, although it is clear that they exert their function through soluble factors without direct interaction with APCs. Each of these suppressor subsets acts in different ways to regulate antigen-specific T cell responses. Functional alterations were shown to be associated with the relapse of autoimmune diseases and onset of acute rejection episodes in transplanted recipients.
In the present study, we have demonstrated that the frequency of peripheral blood Tregs/suppressor T cells increases in association with aging. Our study included donors over 70 years of age, in whom particularly high numbers of CD8 ϩ CD28 -Tregs were observed with a ninefold increase compared with donors aged between 20 and 30 years.
It is possible that the increasing CD8 ϩ CD28 -together with CD4 ϩ CD25 ϩ Treg frequencies observed in the elderly contribute to immune deficiency and plays a part in the broader decline in adaptive responses during immunosenescence.
In addition, it was observed that individuals with a "healthy immune system" might live longer than those whose immune systems produce autoantibodies [48] . A possible explanation of these observations was that as healthy centenarians are a highly selected population (only ϳ1 in 10,000 human beings reaches 100 years old), survival could be associated with an unusually efficient immune system, devoid of the age-related abnormalities often seen in the "younger" elderly. Studies in healthy centenarians support this idea by showing well-preserved immune functions such as NK cytotoxicity, proliferative responses to mitogenic stimuli, and ability to cope with oxidative stress [48] . Thus, centenarians might also be characterized by a lower frequency of circulating Tregs than younger elderly. Obviously, such a hypothesis would require experimental support.
Finally, the high expression of CD122/IL-2/IL-15R␤ could suggest that high levels of this receptor may allow Tregs to act as a cytokine sink, taking important maintenance signals away from other cells and ensuring their own dominance in the aged T lymphocyte pool. If so, one would expect that their response to cytokines that induce proliferation may result in only low proliferation/survival signals. Testing this hypothesis should help to uncover the rules that govern population maintenance and the reasons for their deregulation in the aging immune system.
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